SEPA vs. SRTS, MGRM, ICCM, AMIX, PDEX, HSAQ, APYX, MAQC, NVNO, and DXR
Should you be buying SEP Acquisition stock or one of its competitors? The main competitors of SEP Acquisition include Sensus Healthcare (SRTS), Monogram Orthopaedics (MGRM), IceCure Medical (ICCM), Autonomix Medical (AMIX), Pro-Dex (PDEX), Health Sciences Acquisitions Co. 2 (HSAQ), Apyx Medical (APYX), Maquia Capital Acquisition (MAQC), enVVeno Medical (NVNO), and Daxor (DXR).
SEP Acquisition (NASDAQ:SEPA) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, community ranking, profitability and institutional ownership.
Sensus Healthcare has a consensus price target of $9.00, indicating a potential upside of 70.13%. Given Sensus Healthcare's higher probable upside, analysts clearly believe Sensus Healthcare is more favorable than SEP Acquisition.
Sensus Healthcare has higher revenue and earnings than SEP Acquisition.
In the previous week, Sensus Healthcare had 12 more articles in the media than SEP Acquisition. MarketBeat recorded 14 mentions for Sensus Healthcare and 2 mentions for SEP Acquisition. Sensus Healthcare's average media sentiment score of 0.75 beat SEP Acquisition's score of 0.43 indicating that Sensus Healthcare is being referred to more favorably in the news media.
SEP Acquisition has a beta of 0.16, indicating that its stock price is 84% less volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.
Sensus Healthcare received 177 more outperform votes than SEP Acquisition when rated by MarketBeat users.
Sensus Healthcare has a net margin of 14.70% compared to SEP Acquisition's net margin of 0.00%. Sensus Healthcare's return on equity of 10.01% beat SEP Acquisition's return on equity.
3.7% of SEP Acquisition shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 20.0% of SEP Acquisition shares are owned by insiders. Comparatively, 11.1% of Sensus Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
Sensus Healthcare beats SEP Acquisition on 12 of the 13 factors compared between the two stocks.
Get SEP Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for SEPA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SEPA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SEP Acquisition Competitors List
Related Companies and Tools
